Kinnate Biopharma shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Kinnate Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Kinnate Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kinnate Biopharma by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $149 | 63 | 2.37 |
| 2023-09-30 | $12k | 8.9k | 1.40 |
| 2023-06-30 | $4.7k | 1.5k | 3.03 |
| 2023-03-31 | $149k | 24k | 6.25 |
| 2022-12-31 | $109k | 18k | 6.11 |
| 2022-06-30 | $223k | 18k | 12.74 |
| 2022-03-31 | $247k | 22k | 11.29 |
| 2021-12-31 | $266k | 18k | 14.71 |
| 2021-03-31 | $158k | 5.1k | 31.18 |